Original Research
Published on 16 Jul 2021
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
in Cancer Immunity and Immunotherapy
- 44,297 views
- 121 citations
Original Research
Published on 16 Jul 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Feb 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 02 Sep 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 23 Oct 2020
in Gastrointestinal Cancers
Original Research
Published on 02 Nov 2021
in Head and Neck Cancer
Original Research
Published on 28 Sep 2021
in Molecular and Cellular Oncology
Original Research
Published on 16 Mar 2022
in Computational Genomics
Original Research
Published on 08 Nov 2022
in Cellular Biochemistry
Original Research
Published on 25 May 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 06 Jan 2022
in Surgical Oncology
Original Research
Published on 09 Jun 2023
in Molecular Diagnostics and Therapeutics
Original Research
Published on 10 Oct 2022
in Cellular Endocrinology
Original Research
Published on 03 May 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Aug 2025
in RNA Bioinformatics
Original Research
Published on 09 Nov 2020
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Mar 2019
in Brain Disease Mechanisms